IRIS
PAGNESI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.807
AS - Asia 793
NA - Nord America 674
SA - Sud America 86
AF - Africa 20
OC - Oceania 2
Totale 3.382
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 1.293
US - Stati Uniti d'America 636
SG - Singapore 272
CN - Cina 264
IT - Italia 217
HK - Hong Kong 99
FR - Francia 87
BR - Brasile 58
SE - Svezia 50
GB - Regno Unito 44
VN - Vietnam 40
IN - India 38
DE - Germania 37
PL - Polonia 18
CA - Canada 15
FI - Finlandia 15
MX - Messico 15
JP - Giappone 14
NL - Olanda 14
BD - Bangladesh 11
ES - Italia 11
IQ - Iraq 10
TR - Turchia 9
AR - Argentina 7
AT - Austria 7
SA - Arabia Saudita 7
ZA - Sudafrica 7
CO - Colombia 5
EC - Ecuador 5
PH - Filippine 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
MY - Malesia 4
KW - Kuwait 3
PK - Pakistan 3
PT - Portogallo 3
AZ - Azerbaigian 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
LT - Lituania 2
MA - Marocco 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
UZ - Uzbekistan 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
AW - Aruba 1
BE - Belgio 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
ID - Indonesia 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
PE - Perù 1
RO - Romania 1
SN - Senegal 1
SO - Somalia 1
SR - Suriname 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VI - Stati Uniti Isole Vergini 1
VU - Vanuatu 1
Totale 3.382
Salva come PNG Salva come JPEG
Città #
Moscow 262
Singapore 130
Ashburn 119
Hong Kong 97
Milan 70
Lauterbourg 65
San Jose 65
Beijing 49
Council Bluffs 45
Orem 42
New York 28
Shanghai 26
Dallas 21
Los Angeles 21
Chennai 20
Boardman 19
Santa Clara 16
Warsaw 15
Hefei 14
Ho Chi Minh City 14
Tokyo 14
Brescia 12
Lappeenranta 12
Munich 12
Rome 12
Manchester 11
Poplar 11
Naples 10
Brooklyn 9
Denver 9
Hanoi 8
Lawrence 8
Princeton 8
Amsterdam 7
Frankfurt am Main 7
Nuremberg 7
Phoenix 7
Querétaro 7
São Paulo 7
Atlanta 6
Boston 6
Houston 6
Catania 5
London 5
Montreal 5
Monza 5
Stockholm 5
Turin 5
Bologna 4
Da Nang 4
Ittigen 4
Mumbai 4
Tianjin 4
Washington 4
Ankara 3
Baghdad 3
Caracas 3
Chicago 3
Colliano 3
Delhi 3
Guanzate 3
Guayaquil 3
Johannesburg 3
Kuwait City 3
Mexico City 3
Miami 3
Padua 3
Reggio Emilia 3
Rockville 3
Toronto 3
Verona 3
Vienna 3
Vimodrone 3
Yalova 3
Amman 2
Betim 2
Bexley 2
Bismarck 2
Bucaramanga 2
Buffalo 2
Cagliari 2
Campinas 2
Curitiba 2
Dammam 2
Dhaka 2
Erbil 2
Falkenstein 2
Figino 2
Guangzhou 2
Haiphong 2
Helsinki 2
Jaipur 2
Jeddah 2
Kuala Lumpur 2
Louisville 2
Manila 2
Mareno di Piave 2
New Delhi 2
Newark 2
Palermo 2
Totale 1.500
Salva come PNG Salva come JPEG
Nome #
ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub 119
Impact of Left Ventricular Outflow Tract Calcification on Pacemaker Implantation After Transcatheter Aortic Valve Implantation With Second-Generation Devices 103
Integrated clinical role of echocardiography in patients with COVID-19 94
A novel scoring system and decisional algorithm to predict functional recovery after heart valve surgery 94
Device-related complications after Impella mechanical circulatory support implantation: An IMP-IT observational multicentre registry substudy 94
Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19 92
Heart and Lung Multimodality Imaging in COVID-19 92
Neutrophil to lymphocyte ratio: a new preoperative predictive index of postoperative atrial fibrillation 86
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 75
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 72
First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement 72
Predictors of high residual gradient after transcatheter aortic valve replacement in bicuspid aortic valve stenosis 69
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2 63
Prevalence, Burden and Echocardiographic Features of Moderate to Severe Tricuspid Regurgitation: Insights from a Tertiary Referral Center (vol 3, pg 123, 2019) 60
2024 update in heart failure 55
Epidemiology, pathophysiology, diagnosis and management of atrial functional mitral regurgitation: An expert opinion paper 45
Moderate Secondary Mitral Regurgitation: Evolving Evidence and Management Strategies 43
The Relevance of Right Ventricular Function and Dimension in Patients Undergoing Transcatheter Tricuspid Edge-to-Edge Repair 43
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial 39
Assessing aortic flow with doppler echocardiography in cardiogenic shock: A crucial diagnostic tool 37
Acute Heart Failure: Transitioning From Symptom-Based Care to Remission 36
Management of aortic stenosis and chronic heart failure: A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 36
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction? 36
Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trial 36
Diuretic De-Escalation in Response to HF Therapy: Are We Closer to Reduced Reliance on Diuretics? 35
Decongestion and Outcomes in Patients Hospitalized for Acute Heart Failure: Insights From the RELAX-AHF-2 Trial 35
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 35
Malnutrition and outcomes in patients with tricuspid regurgitation undergoing transcatheter tricuspid valve repair 35
Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF Trial 34
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 33
Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions 32
Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF 32
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 32
Ventilation strategies in cardiogenic shock: Insights from the AltShock-2 registry 31
Left Main Spontaneous Coronary Artery Dissection: Clinical Features, Management, and Outcomes 31
Safety and Efficacy Intravenous Istaroxime up to 60 hours for Patients with Pre-Cardiogenic Shock 31
Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure 31
Impact of mitral regurgitation in patients with acute heart failure: insights from the RELAX-AHF-2 trial 30
April 2021 at a glance: focus on systolic function, quality of life and treatment in heart failure 30
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 29
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials 29
Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysis 29
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure 28
Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis 28
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 28
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 28
Aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE-TR registry 28
Obesity and inflammation in chronic and acute heart failure 28
Prognostic role of tricuspid annular plane systolic excursion/pulmonary artery systolic pressure ratio in patients hospitalized for acute heart failure 27
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 27
Characteristics, Prognosis and ESC/ERS Risk Stratification in Obese Patients with Pulmonary Arterial Hypertension (PAH) 27
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure in elderly patients: a sub-analysis of the STRONG-HF randomized clinical trial 26
Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial 26
Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF 25
Towards a phenotype profiling of the patients with heart failure and preserved ejection fraction 24
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 24
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry 24
Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions: Validation of TRISCORE 24
NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trial 23
Prognostic role of mitral regurgitation in patients with advanced heart failure 23
Early changes in renal function during rapid up-titration of guideline-directed medical therapy following an admission for acute heart failure 23
Noncardiac comorbidities and intensive up-titration of oral treatment in patients recently hospitalized for heart failure: insights from the STRONG-HF trial 23
Reply to the letter regarding the article ‘Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure’ 23
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 23
Safety and Efficacy of Istaroxime 1.0 and 1.5 µg/kg/min for Patients with Pre Cardiogenic Shock 22
Predictors of optimal procedural result after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation 22
Telemedicine for the treatment of heart failure: new opportunities after COVID-19 22
Intra-Aortic Balloon Pumping in Acute Decompensated Heart Failure With Hypoperfusion: From Pathophysiology to Clinical Practice 22
Combined pre- and post-capillary pulmonary hypertension in left heart disease 22
Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial 22
Clinical Impact of Renal Dysfunction in Patients with Severe Tricuspid Regurgitation and Chronic Heart Failure 22
The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC 21
Deep phenotype characterization of hypertensive response to exercise: implications on functional capacity and prognosis across the heart failure spectrum 21
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 21
Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry 21
Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists 21
Heart failure: an update from the last years and a look at the near future 21
Congestion in Patients with Advanced Heart Failure: Assessment and Treatment 21
Functional Mitral Regurgitation and Heart Failure With Preserved Ejection Fraction: Clinical Implications and Management 21
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials 20
Impact of SGLT2 inhibitors on endothelial function and echocardiographic parameters in dilated cardiomyopathy 20
February 2021 at a glance: focus on amyloidosis, myocarditis and cardiomyopathy 20
Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial 20
Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 20
Ejection fraction in heart failure: just become Emperor's new clothes? 19
Is it NICE to measure natriuretic peptides after a hospitalization for heart failure? 19
Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment 19
Differences between cardiogenic shock related to acute decompensated heart failure and acute myocardial infarction 19
Socio-economic status and the effect of guideline-directed medical therapy in the STRONG-HF study 19
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype 19
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial 19
Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF 18
Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction 18
Transcatheter edge-to-edge mitral valve repair for post-myocardial infarction papillary muscle rupture and acute heart failure: A systematic review 18
High troponin levels in patients hospitalized for coronavirus disease 2019: a maker or a marker of prognosis? 18
Mapping of current practices of palliative care for patients with heart failure throughout Europe: A scoping review 17
Remote pulmonary artery pressure-guided management of patients with heart failure: A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 17
Medical therapy for heart failure with preserved ejection fraction: Still a minefield, but with new hope 17
March 2021 at a glance: focus on epidemiology, prevention and COVID-19 17
Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF 17
Totale 3.437
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.876
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202212 0 0 0 7 3 1 0 1 0 0 0 0
2022/202362 19 15 5 0 0 9 0 8 0 0 2 4
2023/202473 0 5 12 10 12 6 2 15 0 0 6 5
2024/2025230 13 11 2 6 10 31 52 31 15 17 16 26
2025/20263.292 85 45 17 113 169 480 382 334 1.385 282 0 0
Totale 3.696